FDA grants 510(k) approval for Arrow Midline with Chlorag+ard Technology,an antithrombogenic and antimicrobial peripheral venous catheter.- Teleflex Inc.

Teleflex Incorporated a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its Arrow Midline with Chlorag+ ard Technology.

Arrow Midline with Chlorag+ ard Technology is an antithrombogenic and antimicrobial peripheral venous catheter designed to minimize common midline catheter complications such as catheter intraluminal occlusion, thrombus accumulation and microbial colonization on the catheter surface for a minimum of 30 days. Additionally, the new Midline is also designed for use with high-pressure injection for diagnostic studies. The Arrow Midline with Chlorag+ ard Technology will enable caregivers to effectively and economically protect the catheter from potential costly complications.

Comment: Pressure-injectable ARROW PICCs (Peripherally Inserted Central Catheters) with Chlorag+ ard Technology are the world�s first FDA-cleared central venous catheters to significantly reduce the risk of central line-associated bloodstream infections (CLABSI) and PICC-related vessel thrombosis,compared to traditional uncoated catheters. They are also the only PICCs in the IV catheter marketplace that have received FDA 510(k) clearance for both broad-spectrum antimicrobial and antithrombogenic protection.